All data are based on the daily closing price as of August 1, 2025
s

Sam Chun Dang Pharm

000250.KQ
136.64 USD
-11.60
-7.83%

Overview

Last close
136.64 usd
Market cap
2.92B usd
52 week high
166.25 usd
52 week low
50.25 usd
Target price
44.1 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
22.4163
Price/Book Value
18.3272
Enterprise Value
3.36B usd
EV/Revenue
22.1753
EV/EBITDA
242.1378

Key financials

Revenue TTM
125.56M usd
Gross Profit TTM
58.92M usd
EBITDA TTM
12.61M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
335.06M usd
Net debt
N/A usd

About

Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.
  • Symbol
    000250.KQ
  • Exchange
    KQ
  • Isin
    KR7000250001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Pharmaceuticals
  • CEO
    Dae-In Yoon
  • Headquarter
    Seoul
  • Web site
    https://www.scd.co.kr

Related news

Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top